China rivalry heats up, Chinese drugmakers are striking major deals with their global counterparts — including some in the ...
A trade group representing generic drugmakers is seeking an injunction to thwart a provision of a new Connecticut law that ...
Pharmacy closures are accelerating, leaving 45 million Americans in pharmacy deserts. Here's how to fix the problem.
In the past two years, patients with dementia and their families have begun to speak about hope in new ways, writes new STAT columnist Jason Karlawish.
Novartis is buying Avidity Biosciences for $12 billion, picking up RNA-based medicines for neuromuscular diseases as it seeks ...
Safeguarding biodiversity is not simply an environmental concern but a foundational element of preventive and clinical care.
Since interagency cooperation isn’t succeeding organically, it’s time for top-down initiatives led by a Health and Human ...
Sometimes the biggest moments at a conference happen backstage. At the annual STAT Summit, that kind of moment involved a ...
Researchers worry that Medicaid home care eligibility decisions are often made without public scrutiny and based less on ...
The Food and Drug Administration on Thursday delivered a split decision on a blood cancer drug from GSK, approving its use in ...
The winners include a gene therapy for a rare form of deafness, a drug for vaping addiction, and a generic antibiotic.
Advocacy groups form a buyer’s club to obtain generic versions of pricey Vertex cystic fibrosis drug
Frustrated by the price of a lifesaving cystic fibrosis treatment sold by Vertex Pharmaceuticals, a group of families is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback